PCRX

Pacira BioSciences
PCRX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.17B
EV
$1.32B
Shares Outstanding
46.28M
Beta
0.71

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
$36.00
P/E 2025E
8.68x
P/Revenue 2025E
1.55x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Pacira BioSciences, Inc.

gainify
PCRX

Pacira BioSciences, Inc.

PCRX

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome inj...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Lee, Frank

Employees

789

IPO Date

2011-02-03

Headquarters

5401 West Kennedy Boulevard, Suite 890, Tampa, Florida, 33609, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved